“…The emergence of widespread antimicrobial resistance (AMR) exhibited now by many commonly encountered pathogens including bacteria (e.g., Gram-positive: Staphylococcus aureus , Streptococcus pyogenes , Mycobacterium tuberculosis , and Clostridium difficile ; and Gram-negative: Escherichia coli , Klebsiella pneumoniae , Salmonella typhi , Pseudomonas aeruginosa , and Neisseria gonorroheae ), viruses (e.g., hepatitis B and C, herpes, and influenza), and fungi (e.g., Candida albicans , Aspergillus fumigatus , and Cryptococcus neoformans ) against a range of popular antimicrobials, such as β-lactam antibiotics, macrolides, tetracyclines, aminoglycosides, fluoroquinolones, antihelminthics, and antifungals ( Singer et al., 2016 ; Naylor et al., 2018 ; Hofer, 2019 ; Laws et al., 2019 ), in both human and veterinary medicine, such as the resistance noted against ivermectin in animal husbandry ( O’Shaughnessy et al., 2019 ), is a major challenge today. Indiscriminate use of antibiotics due to their widespread availability and over-the-counter sales, often without prescription and in conjunction with poor sanitation, inadequate water purification, and wastewater management, as often occurs in developing countries, is posited to be a prime contributing factor to the surge of multidrug-resistant (MDR) strains, including methicillin-resistant Staphylococcus aureus (MRSA, Okwu et al., 2019 ) and vancomycin-resistant Enterococcus (VRE; Cetinkaya et al., 2000 )—collectively termed as the superbugs ( Davies and Davies, 2010 ; Khan and Khan, 2016 ).…”